RASSURE - Virtual Reality to Soothe, Secure, Simulate Uses, and Successfully Complete the Examination (RASSURE)
Pilot Study Evaluating the Impact of Immersive Virtual Reality-Based Habituation to Medical Care Compared With Traditional Habituation to Medical Care on Anxiety Levels in People With Disabilities Receiving Care in a Dedicated Disability Consultation Setting
The RASSURE study aims to evaluate the effect of a preparation for care programme combining a traditional habituation method with a digital immersive virtual reality tool ('PREPASOINS_VR'), compared with traditional habituation alone. In particular, the study aims to measure the impact of the use of IVR on the anxiety experienced during the actual treatment, as well as on various indicators relating to the delivery of the treatment, its progress and the experience of the patients.
研究概览
地位
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Aurélie Dr DURUFLE, Principal Investigator
- 电话号码:+33299295099
- 邮箱:aurelie.durufle@fondationsainthelier.com
学习地点
-
-
-
Rennes、法国
- Fondation Saint-Hélier
-
接触:
- Aurélie DURUFLE
- 电话号码:+33299295099
- 邮箱:aurelie.durufle@fondationsainthelier.com
-
Thorigné-Fouillard、法国
- MAS le Placis Vert - DAPAH - CHGR
-
接触:
- CELINE BUCHAILLET
- 电话号码:0223271133
- 邮箱:c.buchaillet@ch-guillaumeregnier.fr
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
-
Adults:
- Adults (age ≥ 18) at the time of enrollment
- Users of the Handi Accès 35 program who have experienced treatment failure in mainstream healthcare settings
- Individuals with a psychological or mental disability (e.g., autism spectrum disorders, Pervasive Developmental Disorder (PDD), Down syndrome, cerebral palsy, etc.) that creates significant barriers to accessing care (e.g., failure to receive care, failure due to past experience (perceived/contact-related), refusal of care, architectural barriers, anticipated failure, lack of external care options) documented in the medical record
- Requiring a period of adjustment to care
- Having given free and informed consent
- Able to understand the French language (care acclimatization kits-available only in French)
- Enrolled in a social security program or eligible for an equivalent benefit
Minors:
- Children aged between 9 and 17 (inclusive) at the time of inclusion
- Users of the Handi Accès 35 scheme who have been unable to access care in mainstream settings
- People with a psychological or mental disability (for example: autism spectrum disorders, Pervasive Developmental Disorder (PDD), Down's syndrome, cerebral palsy, etc.) which creates significant barriers to accessing care (e.g. failure to access care, failure due to experience (perception/interaction), refusal of treatment, architectural barriers, anticipated failure, no external care provision) documented in the medical record
- Requiring a period of adjustment to care
- Registered with a social security scheme or entitled to an equivalent benefit
- Able to understand French (care familiarisation kits - available in French only)
- Minors for whom free, informed and written consent has been obtained from both holders of parental authority or, in exceptional cases, from a single holder under the conditions set out in Article L1122-2 of the Public Health Code.
Caregivers:
- Adult: a person aged 18 or over
- Informed consent: voluntary agreement to participate in the study following a full explanation of its terms.
- Registered with a social security scheme or an eligible dependant
- Agree to and be able to carry out the treatment familiarisation process with their relative and to accompany them to the dedicated consultation
Exclusion Criteria:
-
majors : Participants requiring urgent medical care that prevents them from completing an 8-week familiarisation period with the treatment
- Participants at high risk of epileptic seizures, or with uncontrolled epilepsy in the investigator's judgement, which contraindicates the use of VR.
- Individuals with visual impairments that make the use of VR impossible
- Individuals who refuse to wear the VR headset, in the investigator's judgement
- Pregnant or breastfeeding women
- Individuals deprived of their liberty by a judicial decision (excluding guardianship or curatorship) or an administrative decision.
- Individuals in an emergency situation who are unable to give their prior consent.
minors : Individuals requiring urgent care that prevents them from completing an 8-week acclimatisation period
- Refusal expressed by the child, notwithstanding the prior consent of the parents or holders of parental authority
- Children subject to a court-ordered protection measure involving a specific placement, which is incompatible with participation in the study
- A person presenting a major risk of epileptic seizures, or uncontrolled epilepsy in the investigator's judgement, which contraindicates the use of VR.
- A person with visual impairments that make the use of VR impossible
- A person refusing to wear the VR headset, in the investigator's judgement
- Individuals deprived of their liberty by a judicial decision (excluding guardianship or curatorship) or an administrative decision.
- Individuals in an emergency situation who are unable to give their prior consent.
Caregiver: Vulnerable individuals referred to in Articles L. 1121-5 to 8 and L. 1122-1-2 of the Public Health Code are excluded from the study:
- Pregnant women, women in labour or breastfeeding women
- Persons deprived of their liberty by a judicial decision (including guardianship, curatorship and judicial protection) or an administrative decision
- Persons receiving psychiatric care or admitted to a health or social care facility for purposes other than research
- Persons in an emergency situation who are unable to give their prior consent
学习计划
研究是如何设计的?
设计细节
- 主要用途:卫生服务研究
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器:Traditional treatment habituation method only
For each group, once they have been briefed, the following materials will be provided:
|
A traditional care habituation programme designed to familiarise participants with upcoming medical and care procedures. The programme uses conventional preparation materials and information to help participants understand and anticipate the different stages of the procedures. It aims to reduce anxiety associated with medical and care procedures. This intervention is provided to participants in both the control and experimental groups. In the experimental group, it is supplemented by an immersive virtual reality familiarisation programme (PREPASOINS_VR). The Embrace Plus wristband is worn by participants in both study groups to monitor anxiety levels during the study. It is used as a monitoring device and does not deliver any therapeutic intervention. A non-electronic dummy wristband used during the treatment habituation sessions to familiarise participants with wearing a wristband before the actual treatment procedure. The dummy wristband is used for habituation purposes only and does not record or monitor physiological parameters. |
|
实验性的:Traditional care habituation combined with virtual reality
In addition to the traditional care habituation materials provided to participants in the control group, participants in this group will also receive:
The virtual reality programme includes eight care scenarios covering dental care, dental mobile unit visits, gynaecological and ophthalmological consultations, follow-up appointments for physical medicine and rehabilitation, somatic assessments, blood tests and electrocardiograms. |
A traditional care habituation programme designed to familiarise participants with upcoming medical and care procedures. The programme uses conventional preparation materials and information to help participants understand and anticipate the different stages of the procedures. It aims to reduce anxiety associated with medical and care procedures. This intervention is provided to participants in both the control and experimental groups. In the experimental group, it is supplemented by an immersive virtual reality familiarisation programme (PREPASOINS_VR). The Embrace Plus wristband is worn by participants in both study groups to monitor anxiety levels during the study. It is used as a monitoring device and does not deliver any therapeutic intervention. A non-electronic dummy wristband used during the treatment habituation sessions to familiarise participants with wearing a wristband before the actual treatment procedure. The dummy wristband is used for habituation purposes only and does not record or monitor physiological parameters. An immersive virtual reality headset used with the PREPASOINS_VR solution. The device enables participants to view immersive 360-degree videos presenting different medical and care scenarios as part of the care familiarisation programme. It is used exclusively in the experimental group. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Skin Conductance (SC) During the Actual Treatment Procedure (µS)
大体时间:At Visit 1, during the actual treatment procedure (2-3 months after enrolment).
|
Skin conductance (SC), expressed in microsiemens (µS), measured using an Empatica wristband during the actual treatment procedure at Visit 1. Skin conductance reflects changes in the electrical conductance of the skin associated with sweat secretion by the eccrine sweat glands, particularly those located on the palms and soles. Skin conductance is a physiological measure of electrodermal activity (EDA) associated with sympathetic nervous system activity. |
At Visit 1, during the actual treatment procedure (2-3 months after enrolment).
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change From Baseline in Caregiver-Reported Patient Anxiety Score on the Visual Analogue Scale at 2-3 Months
大体时间:At baseline (inclusion) and at Visit 1 (2-3 months after enrolment).
|
Patient anxiety score as perceived and reported by the caregiver, measured using a Visual Analogue Scale (VAS) ranging from 0 to 10, where 0 indicates no anxiety and 10 indicates maximum anxiety. The assessment is performed at inclusion (baseline) and at Visit 1 (2-3 months after enrolment). The change in anxiety score between baseline and Visit 1 will be reported. Higher scores indicate higher levels of perceived anxiety (worse outcome). |
At baseline (inclusion) and at Visit 1 (2-3 months after enrolment).
|
|
Percentage of Care Provided During the Actual Treatment Procedure (%)
大体时间:Visit 1, during the actual treatment procedure (2-3 months after enrolment).
|
The degree of care provision during the actual treatment procedure, assessed by the healthcare professional using a numerical scale ranging from 0% (care not provided) to 100% (care fully provided). Intermediate values indicate partial care provision. A derived categorical variable will also be reported, distinguishing complete care provision (100%) from incomplete care provision (partial care provision or no care provided). |
Visit 1, during the actual treatment procedure (2-3 months after enrolment).
|
|
Use of Premedication Before the Treatment Procedure (Yes/No)
大体时间:At Visit 1 (between 2 and 3 months after enrolment).
|
Use of premedication before the actual treatment procedure, recorded as a binary variable (yes/no). When premedication is used, its type (pharmacological or non-pharmacological) will also be recorded. For pharmacological premedication, the medication name and dose will be documented, when applicable. |
At Visit 1 (between 2 and 3 months after enrolment).
|
|
Use and Acceptance of Conscious Sedation With Nitrous Oxide/Oxygen (MEOPA)
大体时间:During the actual treatment procedure at Visit 1 (2-3 months after enrolment).
|
Use of conscious sedation with nitrous oxide/oxygen (MEOPA) during the actual treatment procedure, recorded as a categorical variable: administered and accepted, refused, or not used. |
During the actual treatment procedure at Visit 1 (2-3 months after enrolment).
|
|
Duration of Conscious Sedation With Nitrous Oxide/Oxygen (MEOPA) (Minutes)
大体时间:During the actual treatment procedure at Visit 1 (2-3 months after enrolment).
|
Duration of MEOPA administration during the actual treatment procedure, measured in minutes among participants who receive conscious sedation. |
During the actual treatment procedure at Visit 1 (2-3 months after enrolment).
|
|
Number of Preparatory Visits Before the Actual Treatment Procedure
大体时间:From enrolment until the actual treatment procedure at Visit 1 (2-3 months after enrolment).
|
Number of preparatory visits ("dry runs") completed before the actual treatment procedure. A preparatory visit is defined as a visit during which the patient attends the treatment setting but the planned treatment is not performed. The total number of preparatory visits completed before the actual treatment will be recorded. |
From enrolment until the actual treatment procedure at Visit 1 (2-3 months after enrolment).
|
|
Pain Score During the Treatment Procedure Measured Using the Postoperative Pain Assessment Grid for Individuals with Intellectual Disabilities (GED-DI)
大体时间:Immediately after the actual treatment procedure at Visit 1 (2-3 months after enrolment)
|
Pain experienced by the patient during the treatment procedure, measured using the Postoperative Version of the Pain Assessment Grid for Individuals with Intellectual Disabilities (Grille d'Évaluation de la Douleur - Déficience Intellectuelle, GED-DI). The scale consists of 27 behavioral items, each scored from 0 to 3, resulting in a total score ranging from 0 to 81. The scale is completed after the treatment by the healthcare professional who performed the procedure, with the assistance of a companion when necessary. Higher scores indicate greater pain intensity (worse outcome). Scores of 6-10 indicate mild pain, while scores of 11 or higher indicate moderate to severe pain. |
Immediately after the actual treatment procedure at Visit 1 (2-3 months after enrolment)
|
|
Caregiver Satisfaction With the Care Provided During the Treatment Procedure
大体时间:Immediately after the actual treatment procedure at Visit 1 (2-3 months after enrolment).
|
Caregiver satisfaction with the care provided during the actual treatment procedure, assessed using a 5-point Likert scale ranging from 1 (very dissatisfied) to 5 (very satisfied). The minimum score is 1 and the maximum score is 5. Higher scores indicate greater satisfaction and a better outcome. The questionnaire is completed by the caregiver, if present during the consultation. |
Immediately after the actual treatment procedure at Visit 1 (2-3 months after enrolment).
|
|
Healthcare Professional-Rated Ease of Performing the Treatment Procedure
大体时间:Immediately after the actual treatment procedure at Visit 1 (2-3 months after enrolment).
|
The perceived ease of performing the actual treatment procedure, assessed by the healthcare professional using a 5-point Likert scale ranging from 1 (very difficult) to 5 (very easy). The minimum score is 1 and the maximum score is 5. Higher scores indicate greater ease of performing the procedure and a better outcome. |
Immediately after the actual treatment procedure at Visit 1 (2-3 months after enrolment).
|
|
Duration of the Treatment Habituation Period (Days)
大体时间:From the first habituation session until the actual treatment procedure at Visit 1 (2-3 months after enrolment).
|
Duration of the treatment habituation period, measured in days from the date of the first habituation session to the date of the actual treatment procedure. The duration is calculated as the number of calendar days between these two dates. |
From the first habituation session until the actual treatment procedure at Visit 1 (2-3 months after enrolment).
|
|
Number of Treatment Habituation Sessions
大体时间:From enrolment until the actual treatment procedure at Visit 1 (2-3 months after enrolment).
|
Total number of habituation sessions completed by each participant between enrolment and the actual treatment procedure. |
From enrolment until the actual treatment procedure at Visit 1 (2-3 months after enrolment).
|
|
Recruitment Rate (%)
大体时间:From the start of recruitment until the end of the recruitment period, up to 12 months
|
Proportion of eligible participants who agreed to participate and were enrolled in the study, calculated as the number of enrolled participants divided by the number of eligible participants approached, multiplied by 100. |
From the start of recruitment until the end of the recruitment period, up to 12 months
|
|
Recruitment Speed (Participants per Month)
大体时间:Up to 12 months
|
Average number of participants enrolled per month during the recruitment period, calculated as the total number of enrolled participants divided by the number of months of active recruitment. |
Up to 12 months
|
|
Eligibility Rate (%)
大体时间:Up to 12 months
|
Proportion of individuals assessed for eligibility who met all study eligibility criteria, calculated as the number of eligible individuals divided by the total number of individuals assessed for eligibility, multiplied by 100. |
Up to 12 months
|
|
participant Refusal Rate (%)
大体时间:Up to 12 months
|
Proportion of individuals approached for study participation who declined to participate, calculated as the number of individuals who refused participation divided by the total number of individuals approached, multiplied by 100. |
Up to 12 months
|
|
Intervention Adherence Rate (%)
大体时间:From enrolment up to Visit 1, up to 3 months
|
Proportion of enrolled participants who completed at least two treatment habituation sessions, calculated as the number of participants completing at least two sessions divided by the total number of enrolled participants, multiplied by 100. |
From enrolment up to Visit 1, up to 3 months
|
|
Acceptance Rate of the Dummy Wristband (%)
大体时间:During the habituation period prior to Visit 1, up to 3 months post-enrolment
|
Proportion of participants who accepted wearing the dummy wristband, calculated as the number of participants who accepted wearing the dummy wristband divided by the total number of participants offered the dummy wristband, multiplied by 100. |
During the habituation period prior to Visit 1, up to 3 months post-enrolment
|
|
Acceptance Rate of the Embrace Plus Wristband on the Treatment Day (%)
大体时间:At Visit 1, up to 3 months post-enrolment
|
Proportion of participants who accepted wearing the Embrace Plus wristband during the actual treatment procedure, calculated as the number of participants who accepted wearing the wristband divided by the total number of participants offered the wristband, multiplied by 100. |
At Visit 1, up to 3 months post-enrolment
|
|
Main Reasons for Non-Participation
大体时间:Up to 12 months
|
Main reasons reported by individuals who declined participation in the study, recorded as categorical data. |
Up to 12 months
|
|
Time Interval Between Initial Contact and Study Inclusion (Days)
大体时间:From initial contact until study inclusion, up to 12 months
|
Time interval, measured in calendar days, between the date of initial contact with the potential participant and the date of study inclusion. |
From initial contact until study inclusion, up to 12 months
|
|
Participant Follow-up Completion Rate (%)
大体时间:From enrolment until Visit 1 (2-3 months after enrolment).
|
Proportion of enrolled participants who completed the planned study follow-up assessment at Visit 1, calculated as the number of participants completing Visit 1 divided by the total number of enrolled participants, multiplied by 100 |
From enrolment until Visit 1 (2-3 months after enrolment).
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- 2026-A01473-48
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.